Literature DB >> 17140772

Impulsivity and bipolar disorder.

P Najt1, J Perez, M Sanches, M A M Peluso, D Glahn, J C Soares.   

Abstract

Impulsivity is frequently associated with bipolar disorder (BD) during manic episodes, but may also be present in euthymic bipolar patients. Aggression is an impulsivity-related behavior also found during manic episodes. The objective of this review is to further clarify the relationship between impulsivity and BD. A search in Medline and Psycinfo databases, combined with a manual search of selected references, was conducted to identify available literature on BD and impulsivity-related features. Although few studies have directly measured impulsivity in BD, available findings suggest that impulsivity is not only state-related, but also a trait component of BD, which could represent a core feature of the illness. Further research exploring the neurobiology of the impulsivity/BD relationship may contribute to elucidate the pathophysiology and to improve the diagnosis and treatment of this severe illness.

Entities:  

Mesh:

Year:  2006        PMID: 17140772     DOI: 10.1016/j.euroneuro.2006.10.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  50 in total

1.  Relationships of impulsiveness and depressive symptoms in alcohol dependence.

Authors:  Andrzej Jakubczyk; Anna Klimkiewicz; Aleksandra Topolewska-Wochowska; Piotr Serafin; Joanna Sadowska-Mazuryk; Julia Pupek-Pyzioł; Kirk J Brower; Marcin Wojnar
Journal:  J Affect Disord       Date:  2011-10-24       Impact factor: 4.839

2.  Positive and Negative Activation in the Mood Disorder Questionnaire: Associations With Psychopathology and Emotion Dysregulation in a Clinical Sample.

Authors:  Ryan W Carpenter; Kasey Stanton; Noah N Emery; Mark Zimmerman
Journal:  Assessment       Date:  2019-05-29

Review 3.  New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions.

Authors:  Chantal Henry; Bruno Etain
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

4.  Developing Dimensional, Pandiagnostic Inhibitory Control Constructs With Self-Report and Neuropsychological Data.

Authors:  Natania A Crane; Alvaro Vergés; Masoud Kamali; Runa Bhaumik; Kelly A Ryan; David F Marshall; Erika F H Saunders; Michelle T Kassel; Anne L Weldon; Melvin G McInnis; Scott A Langenecker
Journal:  Assessment       Date:  2018-02-06

5.  Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.

Authors:  Andrea Aguglia; Ludovico Mineo; Alessandro Rodolico; Maria S Signorelli; Eugenio Aguglia
Journal:  Int Clin Psychopharmacol       Date:  2018-05       Impact factor: 1.659

6.  Behavioral approach system sensitivity and risk taking interact to predict left-frontal EEG asymmetry.

Authors:  Chelsea L Black; Kim E Goldstein; Denise R LaBelle; Christopher W Brown; Eddie Harmon-Jones; Lyn Y Abramson; Lauren B Alloy
Journal:  Behav Ther       Date:  2014-01-30

7.  Biologic Commonalities between Mental Illness and Addiction.

Authors:  Karen J Hartwell; Bryan K Tolliver; Kathleen T Brady
Journal:  Prim psychiatry       Date:  2009-08-01

8.  Can risk-taking be an endophenotype for bipolar disorder? A study on patients with bipolar disorder type I and their first-degree relatives.

Authors:  Ceren Hıdıroğlu; Özlem Demirci Esen; Zeliha Tunca; Sehnaz Neslihan Gűrz Yalçìn; Lauren Lombardo; David C Glahn; Ayşegül Özerdem
Journal:  J Int Neuropsychol Soc       Date:  2013-02-14       Impact factor: 2.892

9.  Abnormal reward system activation in mania.

Authors:  Birgit Abler; Ian Greenhouse; Dost Ongur; Henrik Walter; Stephan Heckers
Journal:  Neuropsychopharmacology       Date:  2007-11-07       Impact factor: 7.853

10.  Lithium, but not valproate, reduces impulsive choice in the delay-discounting task in mice.

Authors:  Meredith E Halcomb; Todd D Gould; Nicholas J Grahame
Journal:  Neuropsychopharmacology       Date:  2013-04-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.